美国达尔令国际 DAR 深 沪
等待开盘 06-26 09:30:00 美东时间
52.995
+0.345
+0.66%
华盛通- 最 高53.10
- 今 开52.92
- 成交量 55.34万股
- 最 低 51.88
- 昨 收 52.65
- 总市值 84.22亿
- 52周最高 66.02
- 市盈率 静 135.16
- 换手率 0.35%
- 52周最低 29.15
- 委 比 -88.89%
- 总股本 1.59亿
- 历史最高 87.59
- 量 比 0.43
- 振 幅 2.32%
- 历史最低 7.78
- 每 手 1
- 风险率 11.73%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Trump renews push for year-round E15 gasoline sales across U.S.
The Trump administration asked Congress on Wednesday to pass a law allowing year-round sales of gasoline blended with 15% ethanol, marking the first formal push by his White House to enact the policy...
06-25 06:54
好时咸味零食业务表现强劲 表现优于LesserEvil
好时公司（HSY）2026年一季度咸味零食板块表现强劲，旗下品牌及收购标的均实现增长，北美该业务净销售额同比增长26%至3.501亿美元。 收购Lesser...
06-24 22:16
美股大行评级 | 美银上调美光科技目标价从950美元升至1500美元，上调迈威尔科技目标价从240美元升至365美元
今日重点评级关注：摩根士丹利：维持杜邦"标配"评级，目标价从52美元升至156美元；蒙特利尔银行：维持Taysha Gene Therapies"跑赢大市"评级，目标价从10美元升至14美元
06-24 14:08
美股大行评级 | 阿斯麦获美银、富国上调目标价最高至2345美元；Needham上调美光科技目标价从500美元升至1550美元
今日重点评级关注：Baird：维持Regenxbio"跑赢大市"评级，目标价从27美元升至32美元；古根海姆：维持Tenax Therapeutics"买入"评级，目标价从34美元升至40美元
06-23 13:48
巴克莱在Darling累计上涨49%后将其初始评级定为平等权重 利好是否已完全反映在股价中
Darling Ingredients年内累计涨幅49%，过去六个月上涨84.3%，当前股价较52周高点仅低3.3%，市场焦点已从其业务质地转向估值水平。巴克莱...
06-23 03:43
Barclays Initiates Coverage On Darling Ingredients with Equal-Weight Rating, Announces Price Target of $58
Barclays analyst Theresa Chen initiates coverage on Darling Ingredients (NYSE:DAR) with a Equal-Weight rating and announces Price Target of $58.
06-22 21:00
U.S. RESEARCH ROUNDUP-Baldwin Insurance Group, Diamondback Energy, Visteon
U.S. RESEARCH ROUNDUP-Baldwin Insurance Group, Diamondback Energy, Visteon June 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Baldwin Insurance Group, Diamondback Energy and Visteon, on Monday. HIGHLIGHTS * Baldwin
06-22 15:47
Darling Ingredients And Its Health Brand Rousselot Announce That The U.S. Patent And Trademark Office Has Granted Patent No. Us12636339 For Nextida GC
Darling Ingredients Inc. (NYSE:DAR) and its health brand Rousselot today announced that the U.S. Patent and Trademark Office (USPTO) has granted Patent No. US12636339 for Nextida GC, a first-of-its-kind collagen peptide
06-04 05:13
美股大行评级 | 富国银行上调英伟达目标价从265美元升至315美元；Alamar、AEVEX获多家大行首予“买入”评级
今日重点评级关注：Needham：维持Artiva Biotherapeutics"买入"评级，目标价从18美元升至41美元；HC Wainwright & Co.：维持SAB Biotherapeutics"买入"评级，目标价从7美元升至10美元
05-13 11:46
